FTRE.US Fortrea Holdings Inc.

Healthcare Life Sciences Tools & Services USA Stocks
20.20 USD
Close of Nov 13, 2026
8.55 26.16
Market cap
USD 1.95B
P/E
-
P/B
3.64x
ROE
-9.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is FTRE.US undervalued?

Graham number

The Graham number of Fortrea Holdings Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Fortrea Holdings Inc. fundamental analysis

No fundamental analysis for Fortrea Holdings Inc. yet.

Fortrea Holdings Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Fortrea Holdings Inc.

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I th…

Full company profile